BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 24223174)

  • 21. Genetic variations in miR-125 family and the survival of non-small cell lung cancer in Chinese population.
    Wu S; Shen W; Yang L; Zhu M; Zhang M; Zong F; Geng L; Wang Y; Huang T; Pan Y; Cao S; Dai J; Ma H; Wu J
    Cancer Med; 2019 May; 8(5):2636-2645. PubMed ID: 30843663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between a functional variant in microRNA-27a and susceptibility to colorectal cancer in a Chinese Han population.
    Cao Y; Hu J; Fang Y; Chen Q; Li H
    Genet Mol Res; 2014 Sep; 13(3):7420-7. PubMed ID: 25222241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between polymorphisms of DNA repair genes and survival of advanced NSCLC patients treated with platinum-based chemotherapy.
    Ren S; Zhou S; Wu F; Zhang L; Li X; Zhang J; Xu J; Lv M; Zhang J; Zhou C
    Lung Cancer; 2012 Jan; 75(1):102-9. PubMed ID: 21676483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic variants in the PI3K/PTEN/AKT/mTOR pathway predict platinum-based chemotherapy response of advanced non-small cell lung cancers in a Chinese population.
    Xu JL; Wang ZW; Hu LM; Yin ZQ; Huang MD; Hu ZB; Shen HB; Shu YQ
    Asian Pac J Cancer Prev; 2012; 13(5):2157-62. PubMed ID: 22901187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum.
    Liao WY; Ho CC; Tsai TH; Chen KY; Shih JY; Yu CJ
    Lung Cancer; 2018 Apr; 118():90-96. PubMed ID: 29572009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of functional LIG4 polymorphism on platinum-based chemotherapy response and survival in non-small cell lung cancer.
    Jiang YH; Xu XL; Ruan HH; Xu WZ; Li D; Feng JG; Han QB; Mao WM
    Med Oncol; 2014 May; 31(5):959. PubMed ID: 24722796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between polymorphisms in pre-miRNA genes and risk of lung cancer in a Chinese non-smoking female population.
    Yin Z; Cui Z; Ren Y; Xia L; Wang Q; Zhang Y; He Q; Zhou B
    Lung Cancer; 2016 Apr; 94():15-21. PubMed ID: 26973201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic variation in a microRNA-502 minding site in SET8 gene confers clinical outcome of non-small cell lung cancer in a Chinese population.
    Xu J; Yin Z; Gao W; Liu L; Yin Y; Liu P; Shu Y
    PLoS One; 2013; 8(10):e77024. PubMed ID: 24146953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of microRNA-based signatures for response and survival for non-small cell lung cancer treated with cisplatin-vinorelbine A ELCWP prospective study.
    Berghmans T; Ameye L; Willems L; Paesmans M; Mascaux C; Lafitte JJ; Meert AP; Scherpereel A; Cortot AB; Cstoth I; Dernies T; Toussaint L; Leclercq N; Sculier JP;
    Lung Cancer; 2013 Nov; 82(2):340-5. PubMed ID: 24007627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A genetic variation in microRNA target site of KRT81 gene is associated with survival in early-stage non-small-cell lung cancer.
    Lee SY; Choi JE; Jeon HS; Hong MJ; Choi YY; Kang HG; Yoo SS; Lee EB; Jeong JY; Lee WK; Lee J; Cha SI; Kim CH; Kim YT; Jheon S; Son JW; Park JY
    Ann Oncol; 2015 Jun; 26(6):1142-1148. PubMed ID: 25716425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic variants in microRNAs predict non-small cell lung cancer prognosis in Chinese female population in a prospective cohort study.
    Lingzi X; Zhihua Y; Xuelian L; Yangwu R; Haibo Z; Yuxia Z; Baosen Z
    Oncotarget; 2016 Dec; 7(50):83101-83114. PubMed ID: 27825117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome-wide interrogation identifies YAP1 variants associated with survival of small-cell lung cancer patients.
    Wu C; Xu B; Yuan P; Miao X; Liu Y; Guan Y; Yu D; Xu J; Zhang T; Shen H; Wu T; Lin D
    Cancer Res; 2010 Dec; 70(23):9721-9. PubMed ID: 21118971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between genetic variants in pre-microRNAs and survival of early-stage NSCLC.
    Hong MJ; Choi YY; Jang JA; Jung HJ; Lee SY; Lee WK; Yoo SS; Lee J; Cha SI; Kim CH; Lee E; Jeon HS; Son JW; Park JY
    J Thorac Oncol; 2013 Jun; 8(6):703-10. PubMed ID: 23470291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy.
    Wu X; Ye Y; Rosell R; Amos CI; Stewart DJ; Hildebrandt MA; Roth JA; Minna JD; Gu J; Lin J; Buch SC; Nukui T; Ramirez Serrano JL; Taron M; Cassidy A; Lu C; Chang JY; Lippman SM; Hong WK; Spitz MR; Romkes M; Yang P
    J Natl Cancer Inst; 2011 May; 103(10):817-25. PubMed ID: 21483023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic Variants in the Wingless Antagonist Genes (
    Bahl C; Singh N; Behera D; Sharma S
    Cancer Biother Radiopharm; 2018 Dec; 33(10):466-477. PubMed ID: 30346805
    [No Abstract]   [Full Text] [Related]  

  • 36. Polymorphisms of EpCAM gene and prognosis for non-small-cell lung cancer in Han Chinese.
    Yang Y; Fei F; Song Y; Li X; Zhang Z; Fei Z; Su H; Wan S
    Cancer Sci; 2014 Jan; 105(1):89-96. PubMed ID: 24304228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Significance of ABCG2 Haplotype-tagging Single Nucleotide Polymorphisms in Patients With Unresectable Non-Small Cell Lung Cancer Treated With First-line Platinum-based Chemotherapy.
    Kim SH; Kim MJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Hwang YS; Kim IS; Lee S; Oh SY; Ling H; Lee GW
    Am J Clin Oncol; 2015 Jun; 38(3):294-9. PubMed ID: 23689644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of MSH3 polymorphisms with response and survival in advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy.
    Xu XL; Yao YL; Xu WZ; Feng JG; Mao WM
    Genet Mol Res; 2015 Apr; 14(2):3525-33. PubMed ID: 25966119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive effects of ERCC1 and XRCC3 SNP on efficacy of platinum-based chemotherapy in advanced NSCLC patients.
    Zhou C; Ren S; Zhou S; Zhang L; Su C; Zhang Z; Deng Q; Zhang J
    Jpn J Clin Oncol; 2010 Oct; 40(10):954-60. PubMed ID: 20462983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of the KDM4A rs586339 polymorphism on overall survival in Asian non-small-cell lung cancer patients.
    Marvalim C; Wong JX; Sutiman N; Lim WT; Tan SW; Kanesvaran R; Ng QS; Jain A; Ang MK; Tan WL; Toh CK; Tan EH; Chowbay B
    Pharmacogenet Genomics; 2017 Mar; 27(3):120-123. PubMed ID: 28059867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.